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IntRoduCtIon: The importance of quality indicators has become 
increasingly recognized in gastrointestinal endoscopy. Patient safety 
requires the identification and monitoring of occurrences associated 
with harm or the potential for harm. The identification of relevant 
indicators of safety compromise is, therefore, a critical element that is 
key to the effective implementation of endoscopy quality improve-
ment programs.
oBJeCtIve: To identify key indicators of safety compromise in gas-
trointestinal endoscopy.
MetHods: The Canadian Association of Gastroenterology Safety and 
Quality Indicators in Endoscopy Consensus Group was formed to 
address issues of quality in endoscopy. A subcommittee was formed to 
identify key safety indicators. A systematic literature review was under-
taken, and articles pertinent to safety in endoscopy were identified and 
reviewed. All complications and measures used to document safety were 
recorded. From this, a preliminary list of 16 indicators was compiled and 
presented to the 35-person consensus group during a three-day meeting. 
A revised list of 20 items was subsequently put to the consensus group 
for vote for inclusion on the final list of safety indicators. Items were 
retained only if the consensus group highly agreed on their importance.
ResuLts: A total of 19 indicators of safety compromise were retained 
and grouped into the three following categories: medication-related – 
the need for CPR, use of reversal agents, hypoxia, hypotension, hyper-
tension, sedation doses in patients older than 70 years of age, allergic 
reactions and laryngospasm/bronchospasm; procedure-related early – per-
foration, immediate postpolypectomy bleeding, need for hospital admis-
sion or transfer to emergency department from the gastroenterology unit, 
instrument impaction, severe persistent abdominal pain requiring 
evaluation proven to not be perforation; and procedure-related 
delayed – death within 30 days of procedure, 14-day unplanned hospi-
talization, 14-day unplanned contact with a health provider, gastroin-
testinal bleeding within 14 days of procedure, infection or symptomatic 
metabolic complications.
ConCLusIons: The 19 indicators of safety compromise in endos-
copy, identified by a rigorous, evidence-based consensus process, pro-
vide clear outcomes to be recorded by all facilities as part of their 
continuing quality improvement programs.
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Les indicateurs d’atteinte à la sécurité en cas 
d’endoscopie gastro-intestinale
IntRoduCtIon : On convient de plus en plus de l’importance des 
indicateurs de qualité en endoscopie gastro-intestinale. Pour assurer la 
sécurité des patients, il faut déterminer et surveiller les occurrences 
associées aux dommages et au potentiel de dommages. Il est donc essen-
tiel de déterminer les indicateurs pertinents d’atteinte à la sécurité pour 
la mise en œuvre efficace de programmes d’amélioration de la qualité 
des endoscopies.
oBJeCtIF : Déterminer les principaux indicateurs d’atteinte à la sécu-
rité en cas d’endoscopie gastro-intestinale.
MÉtHodoLoGIe : Le groupe consensuel d’indicateurs de la sécurité 
et de la qualité en endoscopie de l’Association canadienne de gastroenté-
rologie a été formé pour se pencher sur la question de la qualité en endos-
copie. Un sous-comité en est issu pour déterminer les indicateurs de 
sécurité. Il a entrepris une analyse systématique des publications et repéré 
et analysé les articles pertinents pour la sécurité en endoscopie. Il a con-
signé toutes les complications et les mesures utilisées pour attester la 
sécurité. Il en a tiré une liste préliminaire de 16 indicateurs qu’il a com-
pilés et présentés au groupe consensuel de 35 personnesdans le cadre 
d’une réunion de trois jours. Une liste révisée de 20 points a ensuite été 
proposée au groupe consensuel qui devait voter pour établir les éléments 
inclus dans la liste définitive d’indicateurs de sécurité. Les points ont 
ensuite été retenus seulement si le groupe consensuel convenait grande-
ment de leur importance.
RÉsuLtAts : Au total, 19 indicateurs d’atteinte à la sécurité ont été 
retenus et regroupés dans les trois catégories suivantes : liées à des médica-
ments – la nécessité d’une RCR, l’utilisation d’agents d’inversion, l’hypoxie, 
l’hypotension, l’hypertension, les doses de sédation chez les patients de plus 
70 ans, les réactions allergiques et le laryngospasme ou le bronchospasme; 
rapides liées à l’intervention – perforation, hémorragie immédiate après une 
polypectomie, besoin d’une hospitalisation ou d’un transfert de l’unité de 
gastroentérologie à l’urgence, enclavement d’instruments, douleur abdomi-
nale persistante grave qui exige une évaluation démontrant l’absence de 
perforation; et tardives liée à l’intervention – décès dans les 30 jours suivant 
l’intervention, hospitalisation non planifiée au bout de 14 jours, contact 
non planifié avec un professionnel de la santé au bout de 14 jours, hémor-
ragie gastro-intestinale dans les 14 jours suivant l’intervention, infection ou 
complications métaboliques symptomatiques.
ConCLusIons : Les 19 indicateurs d’atteinte à la sécurité en endos-
copie, déterminés par un processus consensuel rigoureux et probant, 
fournissent des résultats clairs que tous les établissements peuvent con-
signer dans le cadre de leurs programmes continus d’amélioration de la 
qualité.
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Gastrointestinal (GI) endoscopy has become increasingly common and important for the diagnosis and treatment of many GI disor-
ders. The central role of colonoscopy in colon cancer screening pro-
grams, both in hospital and stand-alone ambulatory facilities, has 
resulted in a significant increase in the number of procedures per-
formed (1). Most Canadian hospitals provide some level of endoscopy 
services and stand-alone out-of-hospital facilities have become more 
common in many regions of Canada.
As a consequence of the growth of GI endoscopy, there is significant 
variation in service provision, such as choice of medications for sed-
ation, depth of sedation provided, and the training and background of 
the providers (2). A study from the United Kingdom (UK) (3) demon-
strated significant variations in the quality of endoscopy services in dif-
ferent regions. For example, cecal intubation rates ranged from 74.5% at 
district general hospitals to 89.7% at private hospitals. This recognition 
prompted a nationwide program to improve and standardize endoscopy 
services, which has been successful in reducing wait times for endoscopy, 
improving patient satisfaction with endoscopy services and improving 
parameters such as colonoscopy completion rates (4,5).
The importance of quality in endoscopy is increasingly recognized 
worldwide, and efforts are underway in various countries, such as 
Canada, Australia, the United States and the Netherlands, to adopt 
nationwide programs for quality improvement (6). The Canadian 
Association of Gastroenterology (CAG), therefore, formed a commit-
tee to systematically review different aspects of endoscopy and quality, 
with a view to stimulating improvement. This group held a consensus 
conference in June 2010 and generated a broad range of recommenda-
tions, which if adopted, could lead to significant changes in how 
endoscopy services are provided (7). The present article focuses specif-
ically on the patient safety indicators that were developed. These 
indicators are applicable to esophagogastroduodenoscopy (EGD), 
colonoscopy and sigmoidoscopy, but are not intended to encompass 
advanced endoscopic procedures such as endoscopic retrograde chol-
angiopancreatography (ERCP) or advanced interventions such as 
endoscopic mucosal resection.
MetHods
The CAG Safety and Quality Indicators in Endoscopy Consensus 
Group was led by a steering committee of nine people, and had a total 
membership of 35 individuals with knowledge on matters related to 
the provision of endoscopy services, including gastroenterologists, 
surgeons, gastroenterology nurses, health policy experts and a lawyer. 
In addition, nine subcommittees were struck to address specific issues 
in greater detail, including a four-person group that was tasked with 
reviewing the literature surrounding safety in GI endoscopy and rec-
ommending key indicators of safety that all endoscopy units should 
record and track. The methodology behind the consensus group pro-
cess has been described elsewhere (7). The present article will focus 
specifically on the identification and endorsement of safety 
indicators.
Literature search
The steering committee performed a systematic search of PubMed 
from 1990 using the following search terms: “diagnostic errors/adverse 
events”, “diagnostic errors/standards safety”, “adverse events”, “com-
plications”, “mortality”, “colonoscopy”, “quality of health care”, “quality 
control”, “colorectal neoplasms”, “rectal neoplasms”, “adenomatous 
polyps”, “colonic polyps”, “intestinal polyps”, “digestive system neo-
plasms” and “diagnosis”. Additional searches using the same search 
terms were used to identify relevant abstracts from the American 
Gastroenterology Association Digestive Disease Week 2007, 2008 and 
2009, and United European Gastroenterology Week 2007 and 2008.
A total of 2475 citations were identified and assigned in batches to 
pairs of assessors who identified relevant articles for retention. All con-
flicts were resolved by consensus. After two rounds of review, 817 articles 
were retained and made available to the entire consensus group on a 
web portal. The subcommittee on safety searched this database of 
articles to identify articles that specifically dealt with safety issues. The 
references from those articles were reviewed to identify other important 
articles, and additional electronic searches of PubMed were performed 
as necessary. The subcommittee used the articles to determine the 
range of safety compromise indicators that could be considered for col-
lection for systematic monitoring as part of a quality improvement 
program.
Consensus conference and voting
The entire 35-person committee met for a three-day consensus con-
ference in June 2010. During this meeting, the safety compromise 
indicators identified by the safety subcommittee were presented and 
thoroughly discussed during a plenary session. Following discussion, the 
initial list of indicators was revised, after which the entire group voted 
on each safety compromise indicator with respect to its importance and 
whether it should be recommended as a measurable indicator by all 
endoscopy facilities. This voting process occurred via a web portal over 
a one-week period in September 2010. Respondents were asked to 
indicate their level of agreement with each item being an indicator of 
safety in endoscopy using a 6-point Likert scale (disagree strongly, 
disagree moderately, disagree slightly, agree slightly, agree moderately, 
agree strongly). Items were retained only if at least 80% of the consen-
sus group agreed that they were appropriate for inclusion as safety 
indicators (a vote of either agree slightly, agree moderately or agree 
strongly). The voting results determined the final selection of safety 
compromise indicators.
ResuLts
Literature search and consensus
A report from an American Society of Gastrointestinal Endoscopy 
(ASGE) workshop was the only article identified that dealt with the 
broad issue of how endoscopic adverse events (AEs) should be identi-
fied and defined (8). This article was instrumental in determining 
how AEs were considered and classified. The committee adopted the 
definition of an AE proposed by the authors: “An event that prevents 
completion of the planned procedure and/or results in admission to 
hospital, prolongation of existing hospital stay, another procedure 
(needing sedation/anesthesia) or subsequent medical consultation”. 
This was in distinction to an ‘incident,’ which is a minor occurrence 
that does not affect care. The authors suggested that attribution of AEs 
to the endoscopic procedure should be determined and that a classifica-
tion of severity should be recorded. It was also recommended that endos-
copy units record risk factors for AEs, such as patient age and the degree 
of procedural difficulty. These points are summarized in Table 1.
The above definition of an endoscopic AE falls within 
Accreditations Canada’s more general definition of an AE, as an 
“unexpected and undesirable incident directly associated with the care 
or services provided to the client” (9). Sentinel events are a subset of 
AEs that “lead to death or major and enduring loss of function for a 
recipient of healthcare services”. Thus, not all AEs are considered to 
be sentinel events; furthermore, not all reportable incidents are con-
sidered to be AEs. A near miss is an “event or situation that could have 
resulted in an accident, injury or illness to a client but did not, either 
by chance or through timely intervention”. Based on these definitions, 
Accreditation Canada notes that a reporting system for AEs, sentinel 
events and near misses may be part of a larger incident reporting 
system, the aim being to learn from these incidents and prevent 
recurrences (9).
All other articles were observational studies that measured the 
rates of various AEs of interest to those authors or case reports of 
uncommon AEs. The majority of articles addressed AEs following 
colonoscopy (10-33). Articles that described complications from EGD 
(34-38) and sigmoidoscopy (39-41) were also identified.
The safety subcommittee identified 16 indicators of safety com-
promise from the literature review, which were grouped into three 
categories: medication-related, procedure-related early, and procedure-
related delayed (Table 2). At the consensus conference, there was 
general agreement about the importance of each of these items.
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The group discussion about ‘unplanned use of reversal agents’ 
identified several issues that necessitated revision of this indicator. 
From the literature review, it was evident that reversal agents are 
used in some facilities to hasten patient recovery and discharge; such 
an intervention would be planned and would not necessarily indicate 
a sedation-related AE (2). However, the group considered that this 
practice was rare and, furthermore, that it was potentially unsafe. 
Consequently, this indicator was modified to address any ‘use of rever-
sal agents,’ regardless of whether it was planned. An additional indica-
tor – ‘sedation dosages in patients older than 70 years’ – was created to 
reflect the increased risk in this important subgroup (26).
After discussion of ‘bowel preparation-related complications,’ the 
group believed it was appropriate to include bowel preparation-related 
AEs as part of a broader category of general metabolic complications. 
This indicator was revised to reflect this: ‘Symptomatic metabolic 
complications (symptomatic hypo/hyperglycemia, symptomatic elec-
trolyte disturbance)’.
After review of the initial 16 indicators, three additional indica-
tors: ‘unplanned physician contact or visit within 14 days’; ‘severe 
persistent abdominal pain requiring further evaluation and not proven 
as perforation’; and ‘need for admission or transfer to the emergency 
department (ED) from the GI unit for any reason other than under-
lying GI condition’, were developed to ensure that postprocedure 
abdominal pain be recorded specifically (42) and to ensure that any 
unplanned physician contact be captured.
After the main consensus conference, 20 safety compromise indi-
cators, revised to reflect group consensus, were presented via the web 
portal, enabling all participants to vote on the importance of each 
indicator and on their agreement with the need for each indicator to 
be recorded by all endoscopy facilities (Table 3). Consensus (at least 
80% of the group agreed with the statement) was achieved for all 
safety compromise indicators except ‘malfunction of instrument’. Each 
safety compromise indicator is discussed in detail below.
sAFety CoMpRoMIse IndICAtoRs
Medication-related
need for cardiopulmonary resuscitation: The need to initiate cardio-
pulmonary resuscitation (CPR), either to treat ventilatory or circula-
tory impairment, is a serious AE (8). The best available data indicate 
that it occurs infrequently, at a rate of 6.3 per 100,000 endoscopic 
procedures (20).
use of reversal agents; sedation dosages in patients older than 70 years 
of age: Reversal agents, such as flumazenil and naloxone, are used to 
antagonize the sedative effects of benzodiazepines and opiates, 
TaBle 1
Factors to consider when developing an adverse event 
reporting system
Definitions
Adverse event: An event that prevents completion of the planned procedure 
and/or results in admission to hospital, prolongation of existing hospital 
stay, another procedure (needing sedation/anesthesia) or subsequent 
medical consultation
Incident: An unplanned event that does not interfere with completion of the 
planned procedure or change the plan of care
attribution
Definite
Probable
Possible
Unlikely
Severity
Mild (eg, procedure aborted, unplanned hospital admission ≤3 nights)
Moderate (eg, unplanned anesthesia, unplanned hospital admission 4–10 nights)
Severe (eg, unplanned hospital admission >10 nights, ICU admission >1 night)
Fatal
ICU Intensive care unit. Data from reference 8
TaBle 2
Initial list of safety compromise indicators in 
gastrointestinal endoscopy
Safety compromise indicator
Medication related
   Need for cardiopulmonary resuscitation
   Unplanned use of reversal agents
   Allergy
   Laryngospasm/bronchospasm
   Hypoxia (oxygen saturation <85%)
   Hypotension (blood pressure <90/50 mmHg or <20% of baseline)
   Hypertension (blood pressure >190/130 mmHg or >20% of baseline)
Procedure-related early
   Perforation
   Immediate postpolypectomy bleeding
   Impaction of instrument
   Malfunction of instrument
Procedure-related delayed
   Delayed postpolypectomy bleeding
   Unplanned 14-day hospitalization
   Infection (including transmission of viruses)
   30-day mortality
   Bowel preparation-related complications 
TaBle 3
Results of vote by the consensus group on each indicator 
of safety compromise
Indicator
agreement, 
%
Medication related
   Need for cardiopulmonary resuscitation 97.2
   Use of reversal agents 88.6
   Hypoxia (oxygen saturation <85%) 88.6
   Hypotension (BP <90/50 mmHg or ≤20% of baseline) 88.6
   Hypertension (BP >190/130 mmHg or ≥20% of baseline) 80.0
   Sedation doses in patients older than 70 years 82.8
   Allergic reactions 80.0
   Laryngospasm/bronchospasm 80.0
Procedure-related early
   Perforation 100.0
   Immediate postpolypectomy bleeding 94.3
   Need for admission or transfer to the emergency  
 department from the gastroenterology unit for any reason  
 other than underlying GI condition
94.3
   Impaction of instrument 94.3
   Severe persistent abdominal pain requiring further  
 evaluation and proven not to be perforation
91.4
Procedure-related delayed
   Death within 30 days of procedure 94.3
   Unplanned hospitalization occurring within 14 days of  
 the procedure
94.3
   Unplanned contact with health provider occurring within  
14 days of the procedure
91.4
   Gastrointestinal bleeding occurring within 14 days of the  
 procedure
88.6
   Infection – including acute and chronic infections 88.6
   Symptomatic metabolic complication (hypo or  
 hyperglycemia, electrolyte disturbance)
80.0
   Malfunction of instrument 77.1
BP Blood pressure; GI Gastrointestinal
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respectively. Their use is indicative of excess patient sedation and, 
therefore, constitutes an AE (20). A national study of cardiopulmonary 
events following GI endoscopy in the United States found reversal 
agents were required in 490 per 100,000 endoscopic procedures (20). 
An observational study of GI endoscopy services in 21 European cen-
tres found reversal agents were used in 7.7% of procedures, although in 
the majority of cases, its planned use was to hasten patient recovery 
(2). The consensus group agreed that the planned use of these agents 
to expedite patient recovery is not consistent with best practice, and is 
not advised due to the possibility of rebound sedation as the effect of 
the antagonist drug wanes with the patient no longer under 
observation.
Elderly patients are at greater risk for oversedation and sedation-
related AEs. A prospective cohort study showed that patient age >70 years 
is a significant risk factor for prolonged recovery after GI endoscopy 
(25). A study of cardiopulmonary events in the United States found 
increasing patient age to be an independent risk factor, with patients 
>60 years of age almost twice as likely to experience an AE (20). 
Comorbidity, as measured by the American Society of Anesthesia 
(ASA) classification, was also a predictor of unplanned events (20).
A study of 1818 deaths in the United Kingdom within 30 days of 
GI endoscopy found associations between higher sedation doses and 
the need to administer flumazenil, and between flumazenil administra-
tion and patient death (26). The investigators also noted that for the 
same dose of midazolam (5 mg), flumazenil was more often required for 
patients >70 years of age (up to 8% of cases) compared with younger 
patients (<3% of cases) (26).
Based on these data, the consensus group agreed that the use of rever-
sal agents should be included as an indicator of safety compromise. The 
group also agreed that sedation doses in the elderly (patients >70 years of 
age) should be specifically monitored. The optimal sedation dose in this 
patient population is not known, but through measurement and com-
parison with other units, an endoscopy unit will be able to monitor how 
their practice compares with other units, which may enable discrepant 
practices to be identified, reviewed and improved.
Hypoxia
Hypoxia during GI endoscopy may be mild and transient, or severe and 
prolonged. There is no universally recognized threshold or definition for 
hypoxia in GI endoscopy. The consensus group elected to use the def-
inition of hypoxia proposed by the ASGE of oxygen saturation <85% 
(8). It is recognized that some units may choose to use a higher thresh-
old, such as 90%.
An American study of 327,737 procedures at 81 centres (20) pro-
vides the most up to date and comprehensive data regarding cardio-
pulmonary events. In that study, transient hypoxia occurred at a rate of 
240 per 100,000 EGDs and 230 per 100,000 colonoscopies. Transient 
hypoxia occurred most frequently during ERCP (700 per 100,000 cases). 
In contrast, prolonged hypoxia was uncommon, occurring at a rate of 
21 per 100,000 EGDs and 7.8 per 100,000 colonoscopies. The specific 
definitions of both ‘transient’ and ‘prolonged’ hypoxia were not stated.
The risk of clinical sequelae due to hypoxia is not clear (43). 
Moreover, the effects of mild and transient hypoxia are believed to be 
minimal (8). However, it has been shown that intraprocedure hypoxia 
is associated with a greater risk of postprocedural events and prolonged 
recovery time (25).
Most instances of hypoxia during GI endoscopy will be considered 
‘incidents’ (unplanned events that do not interfere with completion of 
the procedure or change the plan of care) rather than AEs. Endoscopy 
units may or may not decide to record episodes of hypoxia that are 
classified as incidents. However, Cotton et al (8) suggested that inci-
dents be recorded by endoscopy facilities as part of comprehensive 
quality improvement to determine whether incidents predict subse-
quent AEs (8); the consensus group agreed with that position.
Hypotension; hypertension
Minor changes in blood pressure may be noted during endoscopy, but 
require no intervention. However, marked changes in blood pressure 
may prevent completion of the procedure, require clinical management 
and have clinical consequences. The optimal threshold or definition of 
both hypotension and hypertension in the setting of GI endoscopy is 
not clear. The group elected to use the definition proposed by the 
ASGE – hypotension <90/50 mmHg or down 20% from baseline; 
hypertension >190/130 mmHg or up 20% from baseline (8).
A large American study of cardiopulmonary events during GI 
endoscopy (20) found that hypotension was fairly common, occurring 
at a rate of 150 per 100,000 EGDs and 480 per 100,000 colonoscopies. 
Hypertension occurred in 22 and 21 of 100,000 EGDs and colonoscopies, 
respectively. Hypertension occurred more frequently during ERCP – at 
a rate of 116 per 100,000 cases. The clinical consequences of these 
events were not reported.
The consensus group agreed that hypotension and hypertension 
should be included in the list of safety indicators (with a stronger level 
of agreement for hypotension). However, it was recognized that most 
events would be classified as incidents rather than AEs. It was agreed 
that recording instances of hypotension and hypertension would serve as 
a general indicator of quality that might enable analysis to determine 
whether such cases were associated with significant AEs subsequently.
Allergic reactions; laryngospasm/bronchospasm
The United States study of cardiopulmonary events (20) found that 
respiratory distress occurred during EGD at a rate of 48 per 100,000, 
and during colonoscopy at a rate of 13 per 100,000 procedures. 
Wheezing and tracheal compression were rare, occurring in no more 
than three cases per 100,000 (20). However, it was noted by the 
ASGE that when such events (including allergic reactions, laryngos-
pasm and bronchospasm) occur as the result of drug administration for 
the purpose of GI endoscopy, they must be recorded as AEs (8). This 
principle may be extended to other adverse drug reactions, such as 
disinhibition caused by benzodiazepines.
procedure-related early
perforation: Perforation of the GI tract is perhaps the most significant 
endoscopic complication. Although the majority of studies investi-
gated the perforation rate for colonoscopy (10-17,19,22-24), articles 
regarding perforation during EGD (34,35) and sigmoidoscopy (39) 
were also identified. The key findings are summarized in Table 4.
The rate of perforation during colonoscopy varied among studies, and 
was as high as one in 769 cases (3). A recent meta-analysis of 17 studies 
and 274,265 colonoscopies (13) reported an overall perforation rate of 
0.035% (95% CI 0.019% to 0.05%) (one in 2857). The perforation 
rate for therapeutic colonoscopy was 0.066% (95% CI 0.025% to 
0.108%) (one in 1515), compared with a rate of 0.017% (95% CI 
0.007% to 0.027%) (one in 5882) for diagnostic colonoscopy. The 
article noted a trend toward lower perforation rates in more recent 
studies, suggesting improving safety over time (13). This might reflect 
improvements in training, technique and endoscopic equipment.
A systematic review of articles published between 2000 and 2008 
identified 15 studies comprising 491,311 colonoscopies (14). The 
overall perforation rate was 0.07% (one in 1428), with the perforation 
rate for therapeutic colonoscopy at 0.1% (one in 1000).
Certain patient- and procedure-related risk factors for perforation 
were noted in many studies, and included polypectomy (11,13-15), 
older age (11,14,16), sex (both male [11] and female [14]), comorbid-
ity (14,16), diverticulosis (14), obstruction as an indication for 
colonoscopy (14,16), invasive procedures other than polypectomy 
(eg, submucosal injection, foreign body removal) (16) and having the 
procedure performed by a low-volume endoscopist (endoscopist per-
forming fewer than 200 to 300 colonoscopies annually) (10,11).
A Canadian study examined 13,792 EGDs and found no perfora-
tions for diagnostic procedures, but a perforation rate of 0.15% (one in 
667) for therapeutic procedures (34). Similarly, in a study of 10,236 
EGDs performed in pediatric patients (35), no perforations were iden-
tified. Studies performed several decades ago, when the medical profes-
sion first adopted EGD as a diagnostic tool, reported perforation rates 
as high as 0.11% (one in 909) (44) and 0.03% (one in 3333) (38).
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Perforation as a result of flexible sigmoidoscopy occurs rarely. A 
review published in 1996 (40) reported a rate of one per 10,000 sig-
moidoscopies. A more recent study (41) found only two cases of per-
foration in 49,501 sigmoidoscopies, indicating a perforation rate of 
approximately one in 25,000. Levin et al (39) examined the complica-
tions of sigmoidoscopy when used exclusively for cancer screening, 
and identified two perforations out of 109,534 sigmoidoscopies.
Immediate postpolypectomy bleeding
Bleeding after polypectomy may not occur for days, or it may occur 
immediately during the procedure. Most studies have focused on 
delayed bleeding (10-12) because most cases of immediate post-
polypectomy bleeding are controlled at the time of the procedure and 
do not affect its completion. It is not clear whether immediate post-
polypectomy bleeding that is controlled endoscopically is of clinical 
consequence. Some authors have suggested that even cases in which 
immediate hemostasis was achieved might represent important events 
and may be risk factors for subsequent adverse bleeding events (8).
A prospective, multicentre, observational study identified 5152 poly-
pectomy patients who had a total of 9336 polyps ≥5 mm in size 
removed endoscopically (18). Immediate postpolypectomy bleeding 
(persisting at least 30 s) occurred in 2.6% of all patients, but only 0.4% 
of all polypectomy patients experienced immediate bleeding that 
required endoscopic therapy. Risk factors independently associated 
with immediate bleeding were the following: age ≥65 years; cardio-
vascular or renal disease; anticoagulant use; polyp >1 cm in size; ped-
unculated polyps; poor bowel preparation; use of cutting current for 
polypectomy; and inadvertently cutting the polyp without applying 
electrocautery. The authors also noted an increased risk of delayed 
bleeding in patients who experienced immediate postpolypectomy 
bleeding (18).
Therefore, although most immediate postpolypectomy bleeding is 
mild or controlled at the time of endoscopy, it does represent a signifi-
cant event, may be a risk factor for subsequent bleeding and should be 
recorded.
need for admission/transfer to the ed
Some patients are transferred to the ED for further management after 
completion of the endoscopic procedure. The group believed that if 
this was part of the ongoing management of the patient’s underlying 
GI illness (eg, hospital admission for severe Crohn’s disease, assess-
ment by surgical service for colon cancer), it should not be recorded as 
an AE. However, all other instances of transfer to the ED should be 
recorded as an AE. Such instances may overlap with other AEs (eg, 
allergic reaction, need for CPR, etc) but will serve as another method 
to ensure important events are identified.
Impaction of instrument
Impaction of an instrument may occur during GI endoscopy, most 
commonly a snare during polypectomy (16,22,45). The results of the 
literature review did not allow for an estimate of the incidence of instru-
ment impaction, but it appears rare. However, it is clearly an important 
event when it occurs and may necessitate surgical therapy (16).
severe, persistent abdominal pain proven not to be perforation, but 
requiring further evaluation 
Abdominal pain is common following colonoscopy. In one randomized 
trial using insufflation with room air (42), 45% and 31% of patients 
had abdominal pain at 1 h and 6 h postcolonoscopy, respectively. 
Abdominal pain usually resolves; however, for some patients, it persists 
to the point that medical attention is required (12,23). The source of 
pain may be identified as perforation, but if not, the pain is often 
attributed to gaseous tension caused by air insufflation (42). Other 
patients with persistent postcolonoscopy pain experience postpolypec-
tomy syndrome (serosal irritation and localized peritonitis due to 
transmural effects of electrocautery) (12). Such patients usually 
require hospitalization and management with antibiotics and, if neces-
sary, surgical intervention.
The consensus group agreed that pain after an endoscopic procedure 
requiring medical evaluation or referral to the ED was a significant AE 
and should be included as an indicator of safety compromise. 
Abdominal pain that resolves without the need for medical attention 
need not be included.
Malfunction of instrument
During any endoscopic procedure, there is potential for instrument 
malfunction that could prevent completion of the procedure or com-
promise patient safety. For example, a broken wire could impair 
colonoscope manoeuverability and increase the risk of perforation if 
the procedure were to continue. The ASGE group recommended that 
endoscopy units record instances of instrument malfunction (8). 
There was very little literature regarding this issue otherwise. When 
this item was put to the group for vote, the level of agreement did not 
meet the prespecified level of 80%. Consequently, this item was not 
retained as one of the recommended safety compromise indicators, 
although it may be one that some endoscopy units choose to track 
nevertheless.
procedure-related delays
death within 30 days of procedure: Mortality following GI endos-
copy is rare but clearly is the most important AE that can occur. A 
30-day period following the procedure has been recommended by most 
authors to ensure capture of events that are delayed, although some 
have suggested that a 14-day time period was adequate (8). If an AE 
occurs that leads to death more than 30 days after the endoscopic 
procedure, than that death should still be recorded.
TaBle 4
Summary of complications of colonoscopy, flexible 
sigmoidoscopy and esophagoduodenoscopy (eGD)
Procedure  
(reference), 
year n Perforation Hemorrhage
Procedure-related  
mortality
Colonoscopy 
(12), 2010
21,375 0.019
(1 in 5344)
0.16
(1 in 629)
0
Colonoscopy 
(13), 2009
274,265 0.035
(1 in 2857)
– –
Colonoscopy 
(14), 2009
491,311 0.07
(1 in 1428)
– –
Colonoscopy 
(15), 2009
277,434 0.082
(1 in 1219)
– –
Colonoscopy 
(10), 2009
24,509 0.12
(1 in 847)
0.086
(1 in 1162)
–
Colonoscopy 
(11), 2008
97,091 0.085
(1 in 1176)
0.164
(1 in 610)
0.0074
(1 in 13,513)
Colonoscopy 
(16), 2006
16,318 0.09
(1 in 1111)
0.5
(1 in 208)
0.006
(1 in 16,318)
Colonoscopy 
(3), 2004
9223 0.13
(1 in 769)
0.065
(1 in 1537)
0.065
(1 in 1537)
Colonoscopy 
(23), 2002
3196 0 0.22
(1 in 455)
–
Sigmoidoscopy 
(14), 2009
109,614 0.04
(1 in 2382)
– –
Sigmoidoscopy 
(39), 2002
109,534 0.0018
(1 in 54,767)
0.0082
(1 in 12,170)
0
Sigmoidoscopy 
(41), 2000
49,501 0.004
(1 in 24,750)
– 0
EGD (35), 2007 10,236 0 0.27
(1 in 366)
0
EGD (34), 2004 13,792 0.06
(1 in 1724)
– 0
Data presented as % unless otherwise indicated
Borgaonkar et al
Can J Gastroenterol Vol 26 No 2 February 201276
Many deaths that occur following GI endoscopy are not related to 
the procedure itself but due to the underlying illness for which the 
procedure was performed or due to another comorbidity. Therefore, it 
is critical that each endoscopy unit review each death to determine 
causation. For example, an American interventional radiology data 
reporting system, the Heath and Inventory Information for Quality, 
classifies deaths as related or unrelated to the procedure (8). The 
National Institutes of Health uses a 4-point scale in which attribution 
is considered to be definite, probable, possible or unlikely (8). 
Recording all deaths and then judging attribution is more complicated 
than only recording deaths that appear to be procedure-related. 
However, it ensures that unexpected deaths due to endoscopy are 
identified.
The mortality rate of GI endoscopy appears to be low. In one study 
of 21,375 outpatient colonoscopies (12), there were three deaths within 
33 days; however, none appeared attributable to the procedure. A study 
from California of 16,318 colonoscopies (16) found only one death 
attributable to colonoscopy. A larger Canadian study of 67,362 out-
patient colonoscopies identified 51 deaths that occurred within 30 days. 
However, chart review determined that three deaths were probably and 
two more were possibly colonoscopy-related, yielding a death rate of 
0.074 per 1000 (one in 13,513 cases) (11). In a study of colonoscopy in 
the UK, Bowles et al (3) found a higher mortality rate of one in 1537 
cases (3). In that study, it was noted that only 17% of endoscopists had 
received supervised training, prompting changes in endoscopy training 
and service delivery, with subsequent improvement in outcomes (4).
The mortality rate for EGD and sigmoidoscopy is lower than that 
for colonoscopies, such that most studies report a mortality rate of 0% 
(34,39,41).
unplanned hospitalization occurring within 14 days of procedure; 
unplanned health provider contact occurring within 14 days of 
procedure
Most studies of the complications of GI endoscopy record the hospital-
ization rate within 14 to 30 days of the procedure. The ASGE work-
shop group recommended a period of 14 days, given that events later 
than this are not very likely to be causally related to the procedure 
(8).
Although perforation and bleeding are the most common compli-
cations of GI endoscopy, many other AEs may occur as a consequence 
of the procedure resulting in the need for hospitalization. Examples of 
AEs that may occur following colonoscopy include, but are not limited 
to, angina or myocardial infarction (3,9,21,22), cerebrovascular acci-
dent (3,23), cardiac dysrhythmia (23), pneumonia (3,10), throm-
bophlebitis (23), splenic rupture (29), postpolypectomy syndrome 
(10,16), diverticulitis (10,16), diabetic ketoacidosis (16), acute renal 
failure (10) and pulmonary embolism (22).
The consensus group agreed with the inclusion of 14-day unplanned 
hospitalization as a safety indicator. This item should capture all serious 
AEs. It was recognized that AEs could occur while preparing for the 
endoscopic procedure. Examples include renal failure due to bowel 
preparation or a thrombotic event due to discontinuation of an anti-
platelet agent. Such AEs should still be recorded and attributed to the 
endoscopic procedure.
As outlined above, there are many possible, but uncommon, AEs 
that may occur after GI endoscopy. Not all require hospitalization (eg, 
phlebitis at intravenous site), but most require assessment by a health 
care provider. To ensure that such events are identified in a monitor-
ing system, the group agreed that any unplanned contact with a health 
care provider (either an in-person visit or communication by another 
means such as telephone or e-mail) be included as an indicator of 
safety.
Gastrointestinal bleeding occurring within 14 days of procedure
Bleeding is the most frequent serious AE following colonoscopy and is 
almost always a result of polypectomy (46). Bleeding may also occur 
following EGD (35). Although some cases are immediate, most are 
delayed and require the patient to seek medical attention.
Almost all studies demonstrate that postpolypectomy bleeding is a 
more common occurrence than perforation. Rabeneck et al (11) found 
a rate of 1.64 per 1000 colonoscopies in a large population-based study 
of several Canadian provinces. Other studies have shown similar rates 
of 2 per 1000 (23), 3.2 per 1000 (16) and 6.4 per 1000 (10). Although 
most cases can be successfully managed conservatively or endoscopic-
ally, postpolypectomy bleeding is considered to be an important AE.
Infection – including acute and chronic infections
Colonoscopy has been implicated in the transmission of both bacterial 
(47) and viral (48) infections. Although the actual risk is not known, 
it appears to be very low (49). Moreover, it is believed that adherence 
to best practices for endoscope reprocessing can essentially eliminate 
the risk of infectious transmission by endoscopes, whereas deviation 
from accepted practices may increase the risk (49).
The consensus group believed that infectious transmission by 
endoscopy was an important safety compromise indicator that should 
be tracked by units. It was recognized that some infections (such as 
Clostridium difficile colitis) would be easier to identify as being endos-
copy related, whereas other infections that might have a delayed 
presentation and diagnosis (such as hepatitis C) could be more diffi-
cult to identify. Not withstanding these challenges, it was believed 
that units must be vigilant in seeking endoscopy-related infectious 
complications.
symptomatic metabolic complications
Colonoscopy requires patients to take a laxative preparation to cleanse 
the colon before the procedure. There is considerable evidence of associ-
ated metabolic derangements such as hypokalemia, hyponatremia, 
hypocalcemia and renal impairment (27,28). Phosphate-containing 
preparations have been associated with acute phosphate nephropathy 
and, as a result, their use is now limited (50). Also, the act of preparing 
for a colonoscopy may interfere with the control of underlying health 
problems, most notably, diabetes mellitus (16).
There was insufficient evidence in the literature to recommend 
that all patients be screened for metabolic abnormalities at the time of 
endoscopic procedures. However, the consensus group beleived that 
symptomatic metabolic disturbances constituted important AEs. Many 
of these events (such as hyperglycemia or dehydration) will be identi-
fied in the endoscopy unit at the time of the procedure. However, 
other events may not become apparent until after the procedure, when 
patients visit health providers or the local ED.
dIsCussIon
The importance of quality improvement in the provision of GI endos-
copy services has been well documented in various countries, such as 
the UK, and has become increasingly recognized elsewhere, including 
Canada (3,6). The association of quality measures with important 
outcomes such as complications and long-term incidence of cancer 
further highlights their importance (51). This is well recognized for 
interval colon cancer following colonoscopy (52), and is also true for 
other events such as post-EGD esophageal and gastric cancer. In one 
study, 10% of all upper GI malignancies were missed during endoscopy, 
equivalent to one missed cancer per 536 procedures (53). A key aspect 
of this process is the recognition of the various AEs that may occur as 
a result of endoscopy and the importance of individual endoscopy 
units recording these. It is only through a systematic approach that 
endoscopy facilities may confidently identify problems and take the 
necessary actions to improve outcomes.
The purpose of the present project was to reach consensus on the key 
safety compromise indicators that all endoscopy units should record. We 
identified 19 indicators based on our literature review and consensus 
process for which there was strong support. The consensus group fol-
lowed the same process to identify quality indicators in GI endoscopy, 
and those results will be published elsewhere.
The next step is to encourage/mandate endoscopy units to prospect-
ively collect information on these indicators as a basis for improving 
the overall quality of endoscopy service delivery. It is recognized that 
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recording many of these indicators will prove to be challenging. There 
is no literature regarding which mechanisms are optimal for recording 
different events. However, it is apparent from the literature review 
that many different methods may be used. Examples include the fol-
lowing: providing patients with contact information for an individual 
to whom they can report AEs (23,54); telephone call follow-up by 
endoscopy unit staff at specified times postprocedure to identify AEs 
(12,23); prospective entry of all procedure-related data, including 
AEs, into a database (20,35); tracking hospital admissions within 
30 days of the procedure through review of administrative databases 
(10,11,16,39); and chart review of admissions following the procedure 
to extract details and determine causation (16,34). This list is not 
all encompassing, and facilities may already have developed locally 
applicable solutions. Table 5 summarizes strategies that may be most 
relevant to each safety indicator. The choice of methods will likely 
depend on the resources available at each endoscopy unit.
We used best practices to develop these indicators, including an 
explicit, reproducible search strategy, seeking broad input from a 
national and international panel of experts with a broad range of 
expertise, and a sophisticated voting process. We believe that it is 
unlikely that important safety indicators were missed. However, the 
list of safety indicators is expected to evolve over time, with items 
being added, omitted, and modified to reflect current evidence and 
best practice. The voting results (Table 3) may be useful to units by 
helping to prioritize items to record.
suMMARy
We endeavoured to follow a process that was systematic, comprehen-
sive and transparent to identify the important indicators of safety 
compromise in GI endoscopy, drawing on both the published literature 
and the experience of a group of health professionals that are involved 
in various aspects of GI endoscopy. We recommend that every endos-
copy unit record and monitor these indicators to ensure best practice 
and the provision of high-quality care.
GRAnt suppoRt: Canadian Institute for Health Research, Canadian 
Partnership Against Cancer.
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